Modelling the first dose of measles vaccination: The role of maternal immunity, demographic factors, and delivery systems

Epidemiology and Infection

Volumn 139, Issue 2, 2011, Pages 265-274

  Metcalf, C J E ^a   Klepac, P ^a   Ferrari, M ^b,c   Grais, R F ^d   Djibo, A ^e   Grenfell, B T ^a,c  

^a PRINCETON UNIVERSITY   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d EPICENTRE   (France)

^e Ministry of Health   (Niger)

Author keywords

Mathematical modelling; measles (rubeola); vaccine policy development

Indexed keywords

ADAPTIVE IMMUNITY; ARTICLE; BIRTH RATE; CHILDHOOD MORTALITY; CONTROLLED STUDY; DRUG DOSE REGIMEN; HEALTH CARE ACCESS; INFECTION RISK; MATHEMATICAL MODEL; MEASLES VACCINATION; MOTHER FETUS RELATIONSHIP; SEASONAL VARIATION; STRATEGIC PLANNING; TREATMENT PLANNING; VIRUS TRANSMISSION; AGING; FEMALE; HEALTH CARE DELIVERY; HUMAN; IMMUNIZATION; IMMUNOLOGY; INFANT; MEASLES; PASSIVE IMMUNIZATION; PREGNANCY; SEASON; THEORETICAL MODEL; VACCINATION;

MEASLES VACCINE;

AGING; DELIVERY OF HEALTH CARE; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION SCHEDULE; INFANT; MEASLES; MEASLES VACCINE; MODELS, THEORETICAL; PREGNANCY; SEASONS; VACCINATION;

EID: 79952218984     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268810001329     Document Type: Article

References (29)

1. Gans HA, et al. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months Journal of the American Medical Association 1998; 280: 527-532.
2. Redd SC, et al. Comparison of vaccination with measles-mumps rubella vaccine at 9, 12 and 15 months of age. Journal of Infectious Diseases 2004; 189: S116-122. (Pubitemid 38639579)
3. Halsey NA, et al. Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illness. New England Journal of Medicine 1985; 313: 544-549. (Pubitemid 15012833)
4. Ceyhan M, et al. Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months as compared to monovalent measles vaccination of children at nine months followed by MMR revaccination at fifteen months of age. Vaccine 2001; 19: 4473-4478. (Pubitemid 32718671)
5. Marks JS, Halpin TJ, Orenstein WA. Measles vaccine efficacy in children previously vaccinated at 12 months of age. Pediatrics 1978; 62: 955-960. (Pubitemid 9037492)
6. Singh R, et al. Immune response to measles, mumps and rubella vaccine at 9, 12 and 15 months of age. Indian Journal of Medical Research 1994; 100: 155-159. (Pubitemid 24325474)
7. Wolfson LJ, et al. Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study. Lancet 2007; 369: 191-200. (Pubitemid 46107682)
8. Wolfson LJ, et al. Estimates of measles case fatality ratios : A comprehensive review of community-based studies. International Journal of Epidemiology 2009; 38: 195-205.
9. WHO/UNICEF. Measles mortality reduction and regional elimination : Strategic plan 2001-2005. Geneva: WHO/UNICEF, 2001.
10. Rosenthal SR, Clements CJ. Two dose measles vaccination schedules. Bulletin of the World Health Organization 1993; 71: 421-428. (Pubitemid 23200087)
11. Grais RF, et al. Unacceptably high mortality related to measles epidemics in Niger, Nigeria and Chad. PLoS Medicine 2007; 4: E16.
12. Clark A, Sanderson C. Timing of children's vaccinations in 45 low-income and middle-income countries : An analysis of survey data. Lancet 2009; 373: 1543-1549.
13. WHO/UNICEF. Joint Annual Measles Report, 2008.
14. Bauch CT, Szusz E, Garrison LP. Scheduling of measles vaccination in low-income countries : Projections of a dynamic model. Vaccine 2009; 27: 4090-4098.
15. Garly ML, et al. Early two-dose measles vaccination schedule in Guinea-Bissau: Good protection and coverage in infancy. International Journal of Epidemiology 1999; 28: 347-352.
16. Earn DJD, et al. A simple model for complex dynamical transitions in epidemics. Nature 2000; 287: 667-670. (Pubitemid 30070917)
17. Ferrari MJ, et al. The dynamics of measles in sub- Saharan Africa. Nature 2008; 451: 679-684. (Pubitemid 351220562)
18. Klepac P, et al. Stage structured transmission of phocine distemper virus in the Dutch 2002 outbreak. Proceedings of the Royal Society of London, Series B 2009; 276: 2469-2476.
19. Klepac P, Caswell H. The stage-structured epidemic: Linking disease and demography with a multi-state matrix model approach. Theoretical Ecology (in press).
20. Bjørnstad ON, Finkenstädt B, Grenfell BT. Endemic and epidemic dynamics of measles: Estimating epidemiological scaling with a time series SIR model. Ecological Monographs 2002; 72: 169-184. (Pubitemid 36198821)
21. Finkenstädt B, Grenfell BT. Time series modelling of childhood diseases : A dynamical systems approach. Journal of the Royal Statistical Society, Series C 2000; 49: 187-205.
22. Grenfell BT, Bjørnstad ON, Finkenstädt BF. Dynamics of measles epidemics. Scaling noise, determinism and predictability with the time series SIR model. Ecological Monographs 2002; 72: 185-202. (Pubitemid 36198822)
23. Glass K, Xia Y, Grenfell BT. Interpreting time-series analyses for continuous-time biological models-measles as a case study. Journal of Theoretical Biology 2003; 223: 19-25. (Pubitemid 36637019)
24. Ferrari MJ, et al. Episodic outbreaks bias estimates of age specific force of infection : A corrected method using measles in Niamey, Niger as an example. Epidemiology and Infection 2010; 138: 108-116.
25. Edmunds WJ, et al. The pre-vaccination epidemiology of measles, mumps and rubella in Europe: Implications for modelling studies. Epidemiology and Infection 2000; 125: 635-650. (Pubitemid 32156852)
26. Schenzle D. Estimation of the basic reproduction number for infectious diseases from age-stratified serological survey data. IMA Journal of Mathematics Applied in Medicine and Biology 1984; 1: 161-191.
27. WHO. Life tables. World Health Organization, 2008.
28. Altintas DU, et al. The modification in measles vaccination age as a consequence of the earlier decline of transplacentally transferred antimeasles antibodies in Turkish infants. European Journal of Epidemiology 2004; 12: 647-648.
29. Klinge J, et al. Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9-11, 12-14 or 15-17 months of age. Vaccine 2000; 18: 3134-3140. (Pubitemid 30345695)